Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors
暂无分享,去创建一个
I. Barshack | T. Meshel | M. Dadiani | A. Ben-Baruch | A. Pavlovski | E. Gal-Yam | Nora Balint-Lahat | Tamir Baram | Nofar Erlichman | Dana Morzaev-Sulzbach | Tsipi Meshel